Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Brentuximab Vedotin in the Treatment of Cutaneuous T Cell Lymphomas: A Multicenter, Retrospective, Case-Control Study from Italy

Erika Morsia, Vieri Grandi, Annagiulia Zizzari, Giacomo Loseto, Paolo Fava, Silvia Alberti Violetti, Alessandro Pileri, Alessandro Broccoli, Paola Vitiello, Antonello Sica, Luca Nassi, Cosimo Di Riamondo, Pietro Quaglino, Nicola Pimpinelli, Emilio Berti, Pier Luigi Zinzani, Serena Rupoli

Blood (2023) 142 (Supplement 1): 6111.

https://doi.org/10.1182/blood-2023-189116

Published: 2023

Journal Articles

A Recent Update of Three Consecutive Prospective Trials with High-Dose Therapy and Autograft, without or with Rituximab, as Primary Treatment for Advanced-Stage Follicular Lymphoma (FL) Shows a Sizeable Group of Patients Surviving in Continuous Complete Remission up to 16 Years After the End of Treatment: Should We Still Consider FL An Incurable Disease ?.

Blood (2009) 114 (22): 882.

https://doi.org/10.1182/blood.V114.22.882.882

Published: 2009

Journal Articles

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Blood (2008) 111 (8): 4004–4013.

https://doi.org/10.1182/blood-2007-10-116749

Published: 2008

Journal Articles

Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment.

Blood (2007) 110 (11): 20.

https://doi.org/10.1182/blood.V110.11.20.20

Published: 2007

Journal Articles

Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo).

Marco Ladetto, Sonia Vallet, Paolo Corradini, Fabio Benedetti, Umberto Vitolo, Maurizio Martelli, Vincenzo Callea, Paolo Coser, Alessio Perrotti, Caterina Patti, Giuseppe Fioritoni, Sergio Morandi, Maurizio Musso, Renato Zambello, Monica Astolfi, Alessandro Pileri, Mario Boccadoro, Corrado Tarella

Blood (2004) 104 (11): 903.

https://doi.org/10.1182/blood.V104.11.903.903

Published: 2004

Journal Articles

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Blood (2002) 100 (5): 1559–1565.

https://doi.org/10.1182/blood-2002-02-0621

Published: 2002

Journal Articles

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

Paolo Corradini, Corrado Tarella, Attilio Olivieri, Alessandro M. Gianni, Claudia Voena, Francesco Zallio, Marco Ladetto, Michele Falda, Moira Lucesole, Anna Dodero, Fabio Ciceri, Fabio Benedetti, Alessandro Rambaldi, Maria R. Sajeva, Moreno Tresoldi, Alessandro Pileri, Claudio Bordignon, Marco Bregni

Blood (2002) 99 (1): 75–82.

https://doi.org/10.1182/blood.V99.1.75

Published: 2002

Journal Articles

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion

Michele Magni, Massimo Di Nicola, Liliana Devizzi, Paola Matteucci, Fabrizio Lombardi, Lorenza Gandola, Fernando Ravagnani, Roberto Giardini, Giuseppe Dastoli, Corrado Tarella, Alessandro Pileri, Gianni Bonadonna, Alessandro M. Gianni

Blood (2000) 96 (3): 864–869.

https://doi.org/10.1182/blood.V96.3.864

Published: 2000

Journal Articles

Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients

Antonio Palumbo, Sabrina Triolo, Chiara Argentino, Sara Bringhen, Alida Dominietto, Cecilia Rus, Paola Omedè, Corrado Tarella, Alessandro Pileri, Mario Boccadoro

Blood (1999) 94 (4): 1248–1253.

https://doi.org/10.1182/blood.V94.4.1248

Published: 1999

Journal Articles

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Massimo Massaia, Paolo Borrione, Silvano Battaglio, Sara Mariani, Eloise Beggiato, Patrizia Napoli, Claudia Voena, Alberto Bianchi, Marta Coscia, Barbara Besostri, Silvia Peola, Thomas Stiefel, Jos Even, Domenico Novero, Mario Boccadoro, Alessandro Pileri

Blood (1999) 94 (2): 673–683.

https://doi.org/10.1182/blood.V94.2.673

Published: 1999

Journal Articles

The Italian Experience on Interferon as Maintenance Treatment in Multiple Myeloma: Ten Years After

Alessandro Pulsoni, Giuseppe Avvisati, Maria Teresa Petrucci, Franco Mandelli, Diana Giannarelli, Vito M. Lauta, Maurizio Tribalto, Alessandro Pileri

Blood (1998) 92 (6): 2184–2186.

https://doi.org/10.1182/blood.V92.6.2184

Published: 1998

Journal Articles

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Paolo Corradini, Monica Astolfi, Cristina Cherasco, Marco Ladetto, Claudia Voena, Daniele Caracciolo, Alessandro Pileri, Corrado Tarella

Blood (1997) 89 (2): 724.

https://doi.org/10.1182/blood.V89.2.724

Published: 1997

Journal Articles

Nucleic Acids and Protein Metabolism in Acute Leukemia Cells

FELICE GAVOSTO, GIOVANNI MARAINI, ALESSANDRO PILERI

Blood (1960) 16 (5): 1555–1563.

https://doi.org/10.1182/blood.V16.5.1555.1555

Published: 1960

Journal Articles

Radioautographic Investigations on DNA and Protein Metabolism in 2 Cases of Di Guglielmo’s Disease

FELICE GAVOSTO, GIOVANNI MARAINI, ALESSANDRO PILERI

Blood (1960) 16 (2): 1122–1132.

https://doi.org/10.1182/blood.V16.2.1122.1122

Published: 1960

NARROW

Brentuximab Vedotin in the Treatment of Cutaneuous T Cell Lymphomas: A Multicenter, Retrospective, Case-Control Study from Italy

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment.

Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo).

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion

Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

The Italian Experience on Interferon as Maintenance Treatment in Multiple Myeloma: Ten Years After

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Nucleic Acids and Protein Metabolism in Acute Leukemia Cells

Radioautographic Investigations on DNA and Protein Metabolism in 2 Cases of Di Guglielmo’s Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only